Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock : a prospective study.
Publicado en: | Biomedicines 10(2022)10, S. 2340 |
---|---|
Autores principales: | Praxenthaler, Janina (Autor), Schwier, Elke (Autor), Altmann, Simon (Autor), Kirchner, Carmen (Autor), Henzler, Dietrich (Autor), Köhler, Thomas (Autor) |
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://pubmed.ncbi.nlm.nih.gov/36289602/ https://doi.org/10.3390/biomedicines10102340 |
Publicación relacionada: | In:
Biomedicines |
Ejemplares similares
-
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
por: Köhler, Thomas, et al.
Publicado: (2022) -
Case report: Early detection of mesenteric ischemia by intravital microscopy in a patient with septic shock
por: Praxenthaler, Janina, et al.
Publicado: (2022) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
por: Schultz, Philipp, et al.
Publicado: (2021) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
por: Köhler, Thomas, et al.
Publicado: (2021) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
por: Schwier, Elke, et al.
Publicado: (2021)